Proscar · DIN 02010909 · 5 mg · tablet
Limited Use, Reason for Use code 384, 385 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 384, 385 required
Write on scriptone applicable Reason for Use code, 384 or 385 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 384, 385
Reason for Use code 384
For use in combination with an alpha blocker for the treatment of men with symptomatic* Benign Prostatic Hyperplasia.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 385
For monotherapy, as a second line agent in patients with symptomatic* Benign Prostatic Hyperplasia following treatment failure or intolerance to an alpha blocker.
Coverage limit:
* Symptomatic is defined as having moderate (about half the time) to severe (almost always) symptoms related to the prostate in at least 4 of the following domains:
1. feeling of incomplete emptying of the bladder after voiding
2. needing to urinate again less than 2 hours after previous void
3. stopping and starting urine several times while voiding
4. difficulty postponing urination
5. weak urinary stream
6. pushing or straining to begin voiding
7. the need to get up to void at least 3 times in the night.
Coverage limit:
LU Authorization Period: Indefinite
Savings card: RxHelp ONE lists Proscar (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
1 brand, same coverage
Proscar · DIN 02010909
Manufacturer: Organon Canada Inc.; listing date 2004-07-20
Health Canada: Marketed since 2022-07-19 · brand PROSCAR · ATC G04CB01 FINASTERIDE · form Tablet · route Oral · ingredients FINASTERIDE 5 MG · company Organon canada inc. · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02010909)
Source record
DIN 02010909: Proscar
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 920000067; group id 915; item number 2189; lccId 00155; manufacturer id OCI
Source form: Tab; strength: 5mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $2.6891; ministry $0.3506
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02010909
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13370
Interchangeable products
Apo-Finasteride · DIN 02365383 · $0.3506
Auro-Finasteride · DIN 02405814 · $0.3506
Finasteride · DIN 02445077 · $0.3506
Finasteride · DIN 02447541 · $0.3506
Finasteride Tablets USP · DIN 02355043 · $0.3506
Jamp-Finasteride · DIN 02357224 · $0.3506
M-Finasteride · DIN 02522489 · $0.3506
Mint-Finasteride · DIN 02389878 · $0.3506
NRA-Finasteride · DIN 02535637 · $0.3506
Novo-Finasteride · DIN 02348500 · $0.3506
PMS-Finasteride · DIN 02310112 · $0.3506
Ratio-Finasteride · DIN 02306905 · $0.3506
Riva-Finasteride · DIN 02455013 · $0.3506
Sandoz Finasteride · DIN 02322579 · $0.3506
Shortage status: not checked (no credentials)